Cigna Corp Stock Buy Recommendation Reiterated (CI)
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.NEW YORK (TheStreet) -- Cigna (NYSE:CI) has been reiterated by TheStreet Ratings as a buy with a ratings score of A . The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.
- ACTIVE STOCK TRADERS: Get trading ideas for stocks under $10 for less than $6/week. Start with a 14-Day Free Trial.
- CI's revenue growth has slightly outpaced the industry average of 26.4%. Since the same quarter one year prior, revenues rose by 35.4%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
- The current debt-to-equity ratio, 0.58, is low and is below the industry average, implying that there has been successful management of debt levels.
- Net operating cash flow has significantly increased by 77.27% to $936.00 million when compared to the same quarter last year. The firm also exceeded the industry average cash flow growth rate of 36.64%.
- Compared to where it was 12 months ago, the stock is up, but it has so far lagged the appreciation in the S&P 500. Turning our attention to the future direction of the stock, it goes without saying that even the best stocks can fall in an overall down market. However, in any other environment, this stock still has good upside potential despite the fact that it has already risen in the past year.
--Written by a member of TheStreet Ratings Staff.FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free Download Now
Latest Headlines about CI
-
5 Buy Signals From the Health Care Sector
06:29AM 06/11/13
-
Boulder Income Fund Is My Berkshire Proxy Trade
09:39PM 05/17/13
-
Cramer: Don't Sleep on Insurers' Strong Move
12:11PM 05/02/13
-
Morning Briefing: 10 Things You Should Know
07:29AM 05/02/13
-
Calling Dr. Henry, Dr. John Henry
06:00AM 03/05/13
-
Analysts' Actions: RIMM BIG DFS EAT FFIV
09:21AM 12/21/12
-
Cigna CEO Sees Growth in Health Care Exchanges
12:59PM 11/26/12
Latest from TheStreet Wire
-
Abbott Laboratories (ABT): Today's Featured Health Services Laggard
05:22PM 06/19/13
-
Petroleo Brasileiro SA Petrobras (PBR): Today's Featured Basic Materials Laggard
05:01PM 06/19/13
-
Microsoft Corporation (MSFT): Today's Featured Computer Software & Services Laggard
05:01PM 06/19/13
-
Target Corp (TGT): Today's Featured Services Laggard
05:01PM 06/19/13
-
Teck Resources Ltd (TCK): Today's Featured Metals & Mining Laggard
05:01PM 06/19/13
-
United Technologies Corp (UTX): Today's Featured Industrial Laggard
05:01PM 06/19/13
-
Texas Instruments Inc. (TXN): Today's Featured Electronics Laggard
05:01PM 06/19/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
